Lymphocytes in inflamed tissues express numerous chemokine receptors. The relative importance of these receptors for migration in inflammation is unclear. The role of CXCR3 in T cell subset migration was examined using monoclonal antibodies developed to rat CXCR3. CXCR3 was expressed on sixfold more CD8 + (*30%) than CD4 + (*5%) T cells in spleen, lymph nodes and blood, and on *10% of CD4 + CD45RC -(memory) and *50% of CD8 + CD45RC + spleen T cells. After immunization, CXCR3 increased tenfold on CD4 + lymph node lymphoblasts (*55%), and >90% of inflammatory exudate T cells were CXCR3 + . CXCR3 + T cells migrated significantly better than CXCR3 -T cells to all dermal inflammatory stimuli tested in vivo, even though these T cells are a minority of the memory T cells. Blocking CXCR3 inhibited recruitment of 60-85% of unstimulated T cells and up to 90% of CD8 + CD45RC + effector T cells, but caused <50% inhibition of CD4 + and CD8 + memory (CD45RC -) T cells. About 90% of T lymphoblast migration to IFN-c, IFN-c plus TNF-a, polyinosinic polycytidylic acid, lipopolysaccharide, and delayed-type hypersensitivity (DTH)-induced inflammation was inhibited. Blockade also reduced DTH-induced induration. Thus, CXCR3 has a nonredundant role in T cell migration to dermal inflammation and is critical for activated T lymphoblast recruitment, but memory T cells are less dependent on CXCR3 for their infiltration.